2026 Q1 -tulosraportti
Vain PDF
97 päivää sitten
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 20.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·3 t sittenstock status All is status quo, but I can see that the pharmacy in Hamburg has many in stock, (dark green dot) but the pharmacy in Dusseldorf has few in stock. (light green dot) However, I cannot see the quantity. Bonus information As is known, I have been looking at stock status since May 13th. After legislation of July 10th, there was a state of chaos. What I have subsequently observed is that the flower medicine of different brands sold out and quickly came back in stock. But as the days went by, I could see that more and more online stores reported sold out, and the flowers did not come back in stock. I wondered about it, but I didn't think much more about it. (It wasn't the flower medicine I was keeping an eye on) It was only after July 29th, when it was announced that the flower medicine had its subsidy withdrawn, that the penny dropped. The German users have naturally hoarded flower medicine, just in case the politicians were serious about it. Those people who were proactive could manage to build up a private stock for at least 6 months' consumption. It has been a blessing in disguise for Stenocare that some of these 65,000 people, who now have to be converted to another product, have hoarded flower medicine. The misfortune consists in that those people who had not hoarded flower medicine, after July 30th, received a prescription for an oil preparation, including Weeco Astrum 10/10, and thereby a greater demand was created, which has led to bottlenecks. Because it all happened within a short period of time, neither Stenocare nor Weeco Pharma could react in time. Germany has very strict legislation regarding cannabis medicine, and that also applies to how much cannabis medicine one is allowed to have in stock. Therefore, it has not been possible for Weeco Pharma to build up a stock, in case this scenario should happen. The fortunate thing is that some people hoarded flower medicine before July 30th, and therefore not all 65,000 users have to be converted to another preparation within a very short period of time, and Germany would thus be completely drained of Weeco Astrum 10/10. I think that both Weeco Pharma and Stenocare have discovered the increased demand, and that more bottles are now being sent than were previously sent to Germany. To ensure that there is oil for everyone, as people's home stocks become empty, and they get a prescription for Weeco Astrum 10/10.
·5 t sittenIt seems some have tried to sell off a lot this past week, not least 100,000 units today. Can anyone see who is selling?- ·1 päivä sittenStock status Canngo: 2 pharmacies in Dusseldorf have bought the oil internally, and therefore have Weeco Astrum 10/10 back in stock. Weeco Pharma has not succeeded in getting a new batch approved, so they can restock the empty shelves again. I hope that will happen soon.I came across this article that has put numbers on how many people have lost their subsidy for flower medicine in Germany as of July 30. The article states 65,000 people. Although not all of them are prescribed Weeco Astrum 10/10, we can conclude that some of these people have received a prescription for Weeco Astrum 10/10 and this demand has led to bottlenecks in the delivery of the oil. Everyone who starts using Weeco Astrum 10/10 and it works as it should, will typically buy 4-6 bottles per year. https://internationalcbc.com/how-many-german-patients-are-impacted-by-cannabis-flower-changes/
·2 päivää sittenI have started doing deeper analysis coverage on the STENOCARE case, which I share via my new Substack (frees up space for the thread here, which from time to time becomes somewhat messy and unserious). Latest post – "STENOCARE: From growth case to maturity plateau – what Q1/Q2 data and the 14-day rates reveal before the Q2 report" – is located here: 👉 https://xcapitalinvestor.substack.com/p/stenocare-fra-vkstcase-til-modenhedsplateau The format is new to me, so feedback is very welcome – both on content and whether it creates value for you. Happy Monday ☕By the way, it's good that cash flow has developed positively, although the surplus is minimal. In that regard, the price pressure is a bit worrying (8% down, that is, so far). It won't take much further headwind before cash flow is red again, and purely financially, it's not as if Steno exactly has much to draw upon.- ·2 päivää sittenIt is both stock status and clarification of the German legislation from July 10, 2026 ( I can't today after 12 PM as I usually do) Stock status Tübingen Apotheke is sold out for the first time. Their stock was emptied last Saturday. The pharmacy is one of the large ones in Germany. It is located in Baden-Württemberg, and when they report sold out, then Weeco Pharma must also not have any more Weeco Astrum 10/10 in their stock. Now the situation is that online stores are slowly starting to report completely sold out of Weeco Astrum 10/10. Cannano reports sold out The others we are monitoring only have a few pharmacies left that have the oil in stock. The pharmacies I can see that still have Weeco Astrum 10/10 in stock are. There is one pharmacy in each of these cities: Hamburg, Nürnberg, Düsseldorf and Nordrhein-Westfalen. Clarification of legislation as of July 10, 2026 The first link is from August 3. Where KVH (regional association of general practitioners) has sent out a message to all doctors, where they clarify the law change from. July 30, that flower medicine will have its subsidy permanently removed. As well as approved and standardized oils will not be affected by the quarantine. Weeco Astrum 10/10 is a standardized cannabis medicinal oil. But there has nevertheless been doubt about how the law change should be understood. Therefore, the doctors and health insurance funds have subsequently sat down together and issued a new message. Here it is established. That the announcement from the doctors on August 3 was correct. For information. It is very important for doctors and pharmacies that they also have the health insurance funds' word on how the new legislation should be understood. Because in Germany, there is the feared and hated regress system. It simply means that if doctors prescribe prescriptions that are not approved with 100% reimbursement, like Weeco Astrum10/10, and the doctors exceed the budget they are given every 3 months, the doctors will have to pay back out of their own pocket. As for the pharmacies, if they come to dispense medicine, here we are talking about flower medicine, after July 10, 2026, without the customer paying for the medicine, i.e., the pharmacies have dispensed flower medicine without taking payment for it, and sent the bill to the insurance company, as they have done for the last two years. These pharmacies that have not understood that since July 10, 2026, the customer should pay themselves, even if the prescription states that there is 100% reimbursement. Pharmacies must therefore pay themselves, out of their own pocket, because they do not receive reimbursement from the health insurance funds. This applies from July 10, 2026 It has emerged that some pharmacies incur an extra expense. Due to the above. ( I have written about the Regress system before, but a lot has happened since then, so I am writing about it again. I believe it is important knowledge to understand the reason why Weeco Pharma has so quickly run into bottleneck problems) The first one sent out by the medical associations. August 3 https://www.kvhh.net/de/praxis/verordnung/verordnung/wichtige-aenderungen-im-arzneimittelbereich-das-gkv-beitragssatzstabilisierungsgesetz-tritt-am-30-juli-2026-in-kraft.html Joint announcement from medical associations and health insurance funds. Doctors and health insurance funds. https://www.hanf-magazin.com/en/kbv-gkv-spitzenverband-klarstellung-cannabis-verordnung/Today's figures: 38.688 that is plus 329,87 % than on Tuesday. but an increase 0,86 % and the price is 0,94 kr.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2026 Q1 -tulosraportti
Vain PDF
97 päivää sitten
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·3 t sittenstock status All is status quo, but I can see that the pharmacy in Hamburg has many in stock, (dark green dot) but the pharmacy in Dusseldorf has few in stock. (light green dot) However, I cannot see the quantity. Bonus information As is known, I have been looking at stock status since May 13th. After legislation of July 10th, there was a state of chaos. What I have subsequently observed is that the flower medicine of different brands sold out and quickly came back in stock. But as the days went by, I could see that more and more online stores reported sold out, and the flowers did not come back in stock. I wondered about it, but I didn't think much more about it. (It wasn't the flower medicine I was keeping an eye on) It was only after July 29th, when it was announced that the flower medicine had its subsidy withdrawn, that the penny dropped. The German users have naturally hoarded flower medicine, just in case the politicians were serious about it. Those people who were proactive could manage to build up a private stock for at least 6 months' consumption. It has been a blessing in disguise for Stenocare that some of these 65,000 people, who now have to be converted to another product, have hoarded flower medicine. The misfortune consists in that those people who had not hoarded flower medicine, after July 30th, received a prescription for an oil preparation, including Weeco Astrum 10/10, and thereby a greater demand was created, which has led to bottlenecks. Because it all happened within a short period of time, neither Stenocare nor Weeco Pharma could react in time. Germany has very strict legislation regarding cannabis medicine, and that also applies to how much cannabis medicine one is allowed to have in stock. Therefore, it has not been possible for Weeco Pharma to build up a stock, in case this scenario should happen. The fortunate thing is that some people hoarded flower medicine before July 30th, and therefore not all 65,000 users have to be converted to another preparation within a very short period of time, and Germany would thus be completely drained of Weeco Astrum 10/10. I think that both Weeco Pharma and Stenocare have discovered the increased demand, and that more bottles are now being sent than were previously sent to Germany. To ensure that there is oil for everyone, as people's home stocks become empty, and they get a prescription for Weeco Astrum 10/10.
- ·5 t sittenIt seems some have tried to sell off a lot this past week, not least 100,000 units today. Can anyone see who is selling?
- ·1 päivä sittenStock status Canngo: 2 pharmacies in Dusseldorf have bought the oil internally, and therefore have Weeco Astrum 10/10 back in stock. Weeco Pharma has not succeeded in getting a new batch approved, so they can restock the empty shelves again. I hope that will happen soon.I came across this article that has put numbers on how many people have lost their subsidy for flower medicine in Germany as of July 30. The article states 65,000 people. Although not all of them are prescribed Weeco Astrum 10/10, we can conclude that some of these people have received a prescription for Weeco Astrum 10/10 and this demand has led to bottlenecks in the delivery of the oil. Everyone who starts using Weeco Astrum 10/10 and it works as it should, will typically buy 4-6 bottles per year. https://internationalcbc.com/how-many-german-patients-are-impacted-by-cannabis-flower-changes/
- ·2 päivää sittenI have started doing deeper analysis coverage on the STENOCARE case, which I share via my new Substack (frees up space for the thread here, which from time to time becomes somewhat messy and unserious). Latest post – "STENOCARE: From growth case to maturity plateau – what Q1/Q2 data and the 14-day rates reveal before the Q2 report" – is located here: 👉 https://xcapitalinvestor.substack.com/p/stenocare-fra-vkstcase-til-modenhedsplateau The format is new to me, so feedback is very welcome – both on content and whether it creates value for you. Happy Monday ☕By the way, it's good that cash flow has developed positively, although the surplus is minimal. In that regard, the price pressure is a bit worrying (8% down, that is, so far). It won't take much further headwind before cash flow is red again, and purely financially, it's not as if Steno exactly has much to draw upon.
- ·2 päivää sittenIt is both stock status and clarification of the German legislation from July 10, 2026 ( I can't today after 12 PM as I usually do) Stock status Tübingen Apotheke is sold out for the first time. Their stock was emptied last Saturday. The pharmacy is one of the large ones in Germany. It is located in Baden-Württemberg, and when they report sold out, then Weeco Pharma must also not have any more Weeco Astrum 10/10 in their stock. Now the situation is that online stores are slowly starting to report completely sold out of Weeco Astrum 10/10. Cannano reports sold out The others we are monitoring only have a few pharmacies left that have the oil in stock. The pharmacies I can see that still have Weeco Astrum 10/10 in stock are. There is one pharmacy in each of these cities: Hamburg, Nürnberg, Düsseldorf and Nordrhein-Westfalen. Clarification of legislation as of July 10, 2026 The first link is from August 3. Where KVH (regional association of general practitioners) has sent out a message to all doctors, where they clarify the law change from. July 30, that flower medicine will have its subsidy permanently removed. As well as approved and standardized oils will not be affected by the quarantine. Weeco Astrum 10/10 is a standardized cannabis medicinal oil. But there has nevertheless been doubt about how the law change should be understood. Therefore, the doctors and health insurance funds have subsequently sat down together and issued a new message. Here it is established. That the announcement from the doctors on August 3 was correct. For information. It is very important for doctors and pharmacies that they also have the health insurance funds' word on how the new legislation should be understood. Because in Germany, there is the feared and hated regress system. It simply means that if doctors prescribe prescriptions that are not approved with 100% reimbursement, like Weeco Astrum10/10, and the doctors exceed the budget they are given every 3 months, the doctors will have to pay back out of their own pocket. As for the pharmacies, if they come to dispense medicine, here we are talking about flower medicine, after July 10, 2026, without the customer paying for the medicine, i.e., the pharmacies have dispensed flower medicine without taking payment for it, and sent the bill to the insurance company, as they have done for the last two years. These pharmacies that have not understood that since July 10, 2026, the customer should pay themselves, even if the prescription states that there is 100% reimbursement. Pharmacies must therefore pay themselves, out of their own pocket, because they do not receive reimbursement from the health insurance funds. This applies from July 10, 2026 It has emerged that some pharmacies incur an extra expense. Due to the above. ( I have written about the Regress system before, but a lot has happened since then, so I am writing about it again. I believe it is important knowledge to understand the reason why Weeco Pharma has so quickly run into bottleneck problems) The first one sent out by the medical associations. August 3 https://www.kvhh.net/de/praxis/verordnung/verordnung/wichtige-aenderungen-im-arzneimittelbereich-das-gkv-beitragssatzstabilisierungsgesetz-tritt-am-30-juli-2026-in-kraft.html Joint announcement from medical associations and health insurance funds. Doctors and health insurance funds. https://www.hanf-magazin.com/en/kbv-gkv-spitzenverband-klarstellung-cannabis-verordnung/Today's figures: 38.688 that is plus 329,87 % than on Tuesday. but an increase 0,86 % and the price is 0,94 kr.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 20.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
2026 Q1 -tulosraportti
Vain PDF
97 päivää sitten
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 20.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·3 t sittenstock status All is status quo, but I can see that the pharmacy in Hamburg has many in stock, (dark green dot) but the pharmacy in Dusseldorf has few in stock. (light green dot) However, I cannot see the quantity. Bonus information As is known, I have been looking at stock status since May 13th. After legislation of July 10th, there was a state of chaos. What I have subsequently observed is that the flower medicine of different brands sold out and quickly came back in stock. But as the days went by, I could see that more and more online stores reported sold out, and the flowers did not come back in stock. I wondered about it, but I didn't think much more about it. (It wasn't the flower medicine I was keeping an eye on) It was only after July 29th, when it was announced that the flower medicine had its subsidy withdrawn, that the penny dropped. The German users have naturally hoarded flower medicine, just in case the politicians were serious about it. Those people who were proactive could manage to build up a private stock for at least 6 months' consumption. It has been a blessing in disguise for Stenocare that some of these 65,000 people, who now have to be converted to another product, have hoarded flower medicine. The misfortune consists in that those people who had not hoarded flower medicine, after July 30th, received a prescription for an oil preparation, including Weeco Astrum 10/10, and thereby a greater demand was created, which has led to bottlenecks. Because it all happened within a short period of time, neither Stenocare nor Weeco Pharma could react in time. Germany has very strict legislation regarding cannabis medicine, and that also applies to how much cannabis medicine one is allowed to have in stock. Therefore, it has not been possible for Weeco Pharma to build up a stock, in case this scenario should happen. The fortunate thing is that some people hoarded flower medicine before July 30th, and therefore not all 65,000 users have to be converted to another preparation within a very short period of time, and Germany would thus be completely drained of Weeco Astrum 10/10. I think that both Weeco Pharma and Stenocare have discovered the increased demand, and that more bottles are now being sent than were previously sent to Germany. To ensure that there is oil for everyone, as people's home stocks become empty, and they get a prescription for Weeco Astrum 10/10.
- ·5 t sittenIt seems some have tried to sell off a lot this past week, not least 100,000 units today. Can anyone see who is selling?
- ·1 päivä sittenStock status Canngo: 2 pharmacies in Dusseldorf have bought the oil internally, and therefore have Weeco Astrum 10/10 back in stock. Weeco Pharma has not succeeded in getting a new batch approved, so they can restock the empty shelves again. I hope that will happen soon.I came across this article that has put numbers on how many people have lost their subsidy for flower medicine in Germany as of July 30. The article states 65,000 people. Although not all of them are prescribed Weeco Astrum 10/10, we can conclude that some of these people have received a prescription for Weeco Astrum 10/10 and this demand has led to bottlenecks in the delivery of the oil. Everyone who starts using Weeco Astrum 10/10 and it works as it should, will typically buy 4-6 bottles per year. https://internationalcbc.com/how-many-german-patients-are-impacted-by-cannabis-flower-changes/
- ·2 päivää sittenI have started doing deeper analysis coverage on the STENOCARE case, which I share via my new Substack (frees up space for the thread here, which from time to time becomes somewhat messy and unserious). Latest post – "STENOCARE: From growth case to maturity plateau – what Q1/Q2 data and the 14-day rates reveal before the Q2 report" – is located here: 👉 https://xcapitalinvestor.substack.com/p/stenocare-fra-vkstcase-til-modenhedsplateau The format is new to me, so feedback is very welcome – both on content and whether it creates value for you. Happy Monday ☕By the way, it's good that cash flow has developed positively, although the surplus is minimal. In that regard, the price pressure is a bit worrying (8% down, that is, so far). It won't take much further headwind before cash flow is red again, and purely financially, it's not as if Steno exactly has much to draw upon.
- ·2 päivää sittenIt is both stock status and clarification of the German legislation from July 10, 2026 ( I can't today after 12 PM as I usually do) Stock status Tübingen Apotheke is sold out for the first time. Their stock was emptied last Saturday. The pharmacy is one of the large ones in Germany. It is located in Baden-Württemberg, and when they report sold out, then Weeco Pharma must also not have any more Weeco Astrum 10/10 in their stock. Now the situation is that online stores are slowly starting to report completely sold out of Weeco Astrum 10/10. Cannano reports sold out The others we are monitoring only have a few pharmacies left that have the oil in stock. The pharmacies I can see that still have Weeco Astrum 10/10 in stock are. There is one pharmacy in each of these cities: Hamburg, Nürnberg, Düsseldorf and Nordrhein-Westfalen. Clarification of legislation as of July 10, 2026 The first link is from August 3. Where KVH (regional association of general practitioners) has sent out a message to all doctors, where they clarify the law change from. July 30, that flower medicine will have its subsidy permanently removed. As well as approved and standardized oils will not be affected by the quarantine. Weeco Astrum 10/10 is a standardized cannabis medicinal oil. But there has nevertheless been doubt about how the law change should be understood. Therefore, the doctors and health insurance funds have subsequently sat down together and issued a new message. Here it is established. That the announcement from the doctors on August 3 was correct. For information. It is very important for doctors and pharmacies that they also have the health insurance funds' word on how the new legislation should be understood. Because in Germany, there is the feared and hated regress system. It simply means that if doctors prescribe prescriptions that are not approved with 100% reimbursement, like Weeco Astrum10/10, and the doctors exceed the budget they are given every 3 months, the doctors will have to pay back out of their own pocket. As for the pharmacies, if they come to dispense medicine, here we are talking about flower medicine, after July 10, 2026, without the customer paying for the medicine, i.e., the pharmacies have dispensed flower medicine without taking payment for it, and sent the bill to the insurance company, as they have done for the last two years. These pharmacies that have not understood that since July 10, 2026, the customer should pay themselves, even if the prescription states that there is 100% reimbursement. Pharmacies must therefore pay themselves, out of their own pocket, because they do not receive reimbursement from the health insurance funds. This applies from July 10, 2026 It has emerged that some pharmacies incur an extra expense. Due to the above. ( I have written about the Regress system before, but a lot has happened since then, so I am writing about it again. I believe it is important knowledge to understand the reason why Weeco Pharma has so quickly run into bottleneck problems) The first one sent out by the medical associations. August 3 https://www.kvhh.net/de/praxis/verordnung/verordnung/wichtige-aenderungen-im-arzneimittelbereich-das-gkv-beitragssatzstabilisierungsgesetz-tritt-am-30-juli-2026-in-kraft.html Joint announcement from medical associations and health insurance funds. Doctors and health insurance funds. https://www.hanf-magazin.com/en/kbv-gkv-spitzenverband-klarstellung-cannabis-verordnung/Today's figures: 38.688 that is plus 329,87 % than on Tuesday. but an increase 0,86 % and the price is 0,94 kr.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt